Maud M. Marques

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Journal: Advances in therapy
Published: December 05, 2025

Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World Setting.

Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World Setting.

Journal: Breast cancer : basic and clinical research
Published: March 21, 2025

Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors.

Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors.

Journal: Biochemical pharmacology
Published: February 05, 2025

Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

Journal: Current oncology (Toronto, Ont.)
Published: May 07, 2024

Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Journal: Cancer research
Published: April 15, 2024

A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy.

A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy.

Journal: International journal of molecular sciences
Published: October 27, 2023

Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada.

Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
Published: September 20, 2023

Carcinogenicity of aspartame, methyleugenol, and isoeugenol.

Carcinogenicity of aspartame, methyleugenol, and isoeugenol.

Journal: The Lancet. Oncology
Published: July 16, 2023

The mechanisms underlying montelukast's neuropsychiatric effects - new insights from a combined metabolic and multiomics approach.

The mechanisms underlying montelukast's neuropsychiatric effects - new insights from a combined metabolic and multiomics approach.

Journal: Life sciences
Published: September 08, 2022

Acetaminophen Induces an Antioxidative Response in Lettuce Plants.

Acetaminophen Induces an Antioxidative Response in Lettuce Plants.

Journal: Plants (Basel, Switzerland)
Published: May 01, 2021

Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine.

Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine.

Journal: Molecules (Basel, Switzerland)
Published: December 31, 2020

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.

Journal: Clinical and translational medicine
Published: November 28, 2020
Showing 1-12 of 61

Last Updated: 09/26/2026